SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MDCO: Medicines Company
MDCO 84.900.0%Jan 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike who wrote (64)3/19/2003 8:42:48 AM
From: Mike  Read Replies (1) of 125
 
Well here we are 12 hours to war and MDCO at a new 52 week high. This company is hitting on all cylinders and we have ACC meeting starting on March 29th. There are quite a few presents at the ACC meeting that include MDCO and Angiomax.



Here is a link to the ACC meeting so you can look over the presentations.

acc.org

The chart has been corrected from the breakdown of a couple weeks ago. We may have some backfilling but I think it is a buy on any of the pullbacks. It is just ashame that no one follows this stock.

I have stated many times that I am not a pumper and dumper. I am an investor in the cardiology field that hunts "idea" stocks. This company prior to Replace II results was an idea stock. Well if you evaluate this trial it is a very strong study. Go back and review all the data and see what is presented at the ACC meeting.

There are many reasons as to why I think MDCO is a diamond in the rough. Here is another. Take a look at SCIO and what has happened to this company for the prior two years.

biz.yahoo.com

Look at the balance sheet and sales for SCIO.

biz.yahoo.com

My contention is that MDCO is one year behind what SCIO's is today. SCIO's is expected to sell $170MM in Natrecor. I personally think that MDCO can do that in Angiomax in 2004. The big item in this comparison is how much did JNJ pay for the pipeline of SCIO. My contention is they got it for free. You be the judge.

This stock is a strong buy at any level below $20.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext